OR WAIT null SECS
June 26, 2008
Also, Stiefel Laboratories will acquire Barrier Therapeutics, Danube Pharmaceuticals appoints Brian Levy COO, more...
May 02, 2008
Scientists are giving up on a preventive vaccine for AIDS, but there are lessons to be learned.
March 25, 2008
Scientists at the University of North Carolina at Chapel Hill have successfully tested a new inhaled tuberculosis (TB) vaccine.
December 20, 2007
Merck & Co. initiated a voluntary recall of 11 lots of its Haemophilus influenzae type B vaccine, Pedvaxhib, and two lots of its combination Haemophilus influenzae type B/ hepatitis B vaccine, Comvax.
November 29, 2007
Sanofi-aventis entered into an agreement with Chinese authorities allowing Sanofi to construct a vaccine-manufacturing plant in Shenzhen municipality.
August 16, 2007
Microbix Biosystems has established a team of experts to help manufacturers boost their production of influenza vaccine.
July 27, 2007
Merck & Co. acquires NovaCardia, Sanofi Pasteur completes vaccine-manufacturing facility, more
July 12, 2007
Novartis Vaccines plans to produce approximately 40 million doses of its ?Fluvirin? vaccine for distribution in the United States during the 2007?2008 flu season.
July 05, 2007
Novartis Vaccines and Diagnostics, a division of Novartis AG (Basel, Switzerland) and IntercellAG (Vienna, Austria), a biotechnology company, will collaborate toward developing a broad range of vaccines.
June 21, 2007
Washington, DC (June 14)-The US Department of Health and Human Services awarded two contracts totaling $132.5 million to Sanofi Pasteur and MedImmune to retrofit their influenza vaccine manufacturing facilities.